Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strimvelis for ADA-SCID
NCT00598481Phase 2Completed
- Sponsor
- Fondazione Telethon
- Start
- Oct 2002
- Primary completion
- Jul 2011
- Modality
- Gene Editing, Gene Silencing, Stem Cell Therapies
- Countries
- 2
01
Overview
A Phase 2 trial of Strimvelis in severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID), sponsored by Fondazione Telethon. Started Oct 2002; status: completed.
02
Drugs
Strimvelis
03
Conditions
severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID)
Beyond the preview
Go deeper on NCT00598481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00598481.